Information Journal Paper
APA:
Copy. (2020). Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis. J Comp Eff Res, 9(4), 275-285. SID. https://sid.ir/paper/671503/en
Vancouver:
Copy. Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis. J Comp Eff Res[Internet]. 2020;9(4):275-285. Available from: https://sid.ir/paper/671503/en
IEEE:
Copy, “Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis,” J Comp Eff Res, vol. 9, no. 4, pp. 275–285, 2020, [Online]. Available: https://sid.ir/paper/671503/en